Home › NDC Lookup › RxCUI directory › RxCUI 2707693

Biotin 2 MG/ML / minoxidil 50 MG/ML Topical Solution — RxCUI 2707693

RxNorm drug concept · Semantic clinical drug
RxCUI 2707693 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 11 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2707693
Official nameBiotin 2 MG/ML / minoxidil 50 MG/ML Topical Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbiotin 0.2 % / minoxidil 5 % Topical Solution
FDA products mapped6
Package NDCs mapped11
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Minoxidil: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • That's a really common question. Minoxidil tablets are very effective at lowering blood pressure, but they cause two side effects that need to be managed: your heart speeds up, and...
  • I've been prescribed minoxidil tablets for blood pressure — why do I need to take other pills with it?
  • It takes patience — most people need at least 2 to 4 months of twice-daily use before they notice any regrowth. Some products note that results can start appearing around the 2-mon...
  • I'm using a topical minoxidil solution for hair loss. How long before I see results?
📖 Read our full Minoxidil guide →

🕸️ Concept Web — How Biotin 2 MG/ML / minoxidil 50 MG/ML Topical Solu... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Biotin 2 MG/ML / minoxidil 50 MG/ML Topical Solution RxCUI 2707693

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Biotin 1588
    • Minoxidil 6984
    • Biotin / minoxidil 2691094
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Biotin / minoxidil Topical Solution 2691096
    • Biotin / minoxidil Topical Product 2691095
    • Topical Solution 316986
    • Topical Product 1151122
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Biotin 2 MG/ML 2707692
    • Minoxidil 50 MG/ML 330042

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Biotin 2 MG/ML SCDC · 2707692
  • Minoxidil 50 MG/ML SCDC · 330042
  • Biotin / minoxidil Topical Solution SCDF · 2691096
  • Biotin / minoxidil Topical Product SCDG · 2691095

📦 FDA Products & Package NDCs

6 products · 11 package NDCs
11 package NDCs map to RxCUI 2707693 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
85304-0001-02 2 BOTTLE in 1 BOX (85304-001-02) / 60 mL in 1 BOTTLE 5% Minoxidil with Biotin Guangzhou Borderless Technology Co., Ltd. 2025-03-11
85304-0001-04 4 BOTTLE in 1 BOX (85304-001-04) / 60 mL in 1 BOTTLE 5% Minoxidil with Biotin Guangzhou Borderless Technology Co., Ltd. 2025-03-11
85304-0001-06 6 BOTTLE in 1 BOX (85304-001-06) / 60 mL in 1 BOTTLE 5% Minoxidil with Biotin Guangzhou Borderless Technology Co., Ltd. 2025-03-11
85304-0025-01 4 BOTTLE in 1 PACKAGE (85304-025-01) / 60 mL in 1 BOTTLE BEHATMH 5% MINOXIDIL HAIR REGROWTH SERUM With Biotin Guangzhou Borderless Technology Co., Ltd. 2026-02-25
85304-0025-02 8 BOTTLE in 1 PACKAGE (85304-025-02) / 60 mL in 1 BOTTLE BEHATMH 5% MINOXIDIL HAIR REGROWTH SERUM With Biotin Guangzhou Borderless Technology Co., Ltd. 2026-02-25
85304-0026-01 3 BOTTLE in 1 PACKAGE (85304-026-01) / 60 mL in 1 BOTTLE NALIOPI 5% minoxidil with biotin topical solution Guangzhou Borderless Technology Co., Ltd. 2026-02-25
85304-0026-02 6 BOTTLE in 1 PACKAGE (85304-026-02) / 60 mL in 1 BOTTLE NALIOPI 5% minoxidil with biotin topical solution Guangzhou Borderless Technology Co., Ltd. 2026-02-25
85304-0027-01 2 BOTTLE in 1 PACKAGE (85304-027-01) / 60 mL in 1 BOTTLE 5% MINOXIDIL HAIR REGROWTH SERUM With Biotin Guangzhou Borderless Technology Co., Ltd. 2026-03-09
85304-0028-01 4 BOTTLE in 1 PACKAGE (85304-028-01) / 60 mL in 1 BOTTLE Tacruitf 5% minoxidil with biotin topical solution Guangzhou Borderless Technology Co., Ltd. 2026-03-24
85304-0028-02 8 BOTTLE in 1 PACKAGE (85304-028-02) / 60 mL in 1 BOTTLE Tacruitf 5% minoxidil with biotin topical solution Guangzhou Borderless Technology Co., Ltd. 2026-03-24
85304-0030-01 5 BOTTLE in 1 PACKAGE (85304-030-01) / 18 mL in 1 BOTTLE TAGOQHIA Minoxidil Hair Thickening Serum Guangzhou Borderless Technology Co., Ltd. 2026-04-03
Observed labelers: Guangzhou Borderless Technology Co., Ltd. (11) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.